Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | ENPP2 | Q13822 | 6/20 | 0.31 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28324564 | 0.90 | SMN1; SMN2 (0.66) | SMN1; SMN2ALDH1A1TDP1TSHRENPP2 | |
| SCHEMBL143771 | 0.79 | — | — | |
| SCHEMBL27314906 | 0.78 | ALDH1A1 (0.33) | SMN1; SMN2ALDH1A1TSHRMAPK1 | |
| SCHEMBL2217198 | 0.78 | ALDH1A1 (0.38) | SMN1; SMN2ALDH1A1TDP1ENPP2LPAR2 | |
| SCHEMBL2216626 | 0.77 | — | — | |
| Water SCHEMBL27814314 | 0.77 | — | — | |
| SCHEMBL17097113 | 0.76 | ALDH1A1 (0.67) | SMN1; SMN2ALDH1A1TSHRMAPK1 | |
| SCHEMBL28582960 | 0.76 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1TDP1TSHR | |
| SCHEMBL28377801 | 0.75 | ALDH1A1 (0.72) | SMN1; SMN2ALDH1A1TDP1TSHRENPP2 | |
| SCHEMBL14205384 | 0.75 | SMN1; SMN2 (0.69) | SMN1; SMN2ALDH1A1TDP1TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111416147-A | Composite solid polymer electrolyte and preparation method thereof | 湖南科技大学 | 2020-07-14 | — | — | CN | disclosed |
| US-20150270574-A1 | HALOGENOSILANE FUNCTIONALIZED CARBONATE ELECTROLYTE MATERIAL, PREPARATION METHOD THEREOF AND USE IN ELECTROLYTE FOR LITHIUM ION BATTERY | GUANGZHOU INSTITUTE OF ENERGY CONVERSION, CHINESE ACADEMY OF SCIENCES (CN) | 2015-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150270574-A1 | HALOGENOSILANE FUNCTIONALIZED CARBONATE ELECTROLYTE MATERIAL, PREPARATION METHOD THEREOF AND USE IN ELECTROLYTE FOR LITHIUM ION BATTERY | CA1, PIEZO1, SLC9A1 | SMN1; SMN2 2854/4885ALDH1A1 1602/4885TDP1 1058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.